(Reuters) – Drugmaker Biogen (NASDAQ:) will buy all outstanding shares of Sage Therapeutics that it…

By Jody Godoy (Reuters) -U.S. antitrust enforcers weighed in on Friday on Elon Musk’s lawsuit…

Investing.com – U.S. stocks were lower after the close on Friday, as losses in the…

Investing.com — The surged to multi-year highs on Friday, hitting a level that an expert said would mark…

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of…

(Reuters) – The U.S. government on Friday released short-term guidance on how companies can secure…